You make some valid points.
If AVE interim results look good in December then BP would start their own trials using TPM alternatives and it would be a race to the FDA finish line.
Who would bother betting on AVE if BP is barely six months behind?
Ann: March 2024 Quarterly Activities Report & Appendix 4C, page-40
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.303K | 454.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 48 | 93441923 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 20076233 | 12 |
View Market Depth
| Last trade - 10.56am 26/06/2024 (20 minute delay) ? |
| AVE (ASX) Chart |